'Club Together On Drug Pricing,' EU Health Chief Tells Member States
This article was originally published in Scrip
The European Health Commissioner, Vytenis Andriukaitis, has called for an "open debate" on the question of drug pricing in Europe, and urged member states to club together to procure medicines in order to negotiate more favorable prices.
You may also be interested in...
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.
The EU’s new health commissioner, Stella Kyriakides, has outlined the commission’s plans for dealing with medicines access issues in the EU member states. They include completing the review of the EU pediatric and orphan legislation and developing a new strategic plan to tackle shortages and affordability problems next year.
AstraZeneca’s Lynparza can now be used on the Scottish National Health Service for newly diagnosed advanced ovarian cancer.